List of shareholders holding at least 5% of the total number of votes at the Extraordinary Shareholder Meeting on 19 May 2026
20.05.2026
See also
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations
Extraordinary Shareholders’ Meeting on 19 May 2026
- Corporate news
- Investor relations
The division of Synektik is complete – the court has registeredthe issue of Syn2bio shares
- Corporate news
- Investor relations